Waking up with some gunk in your eyes is usually nothing to worry about. The scientific name for this crust is rheum, and it forms when oil and other debris collect on your eyelids during sleep. But ...

Please provide your email address to receive an email when new articles are posted on . Demodex blepharitis is so common that it makes up more than two thirds of all blepharitis cases. In fact, nearly ...

Elizabeth Yeu, MD, provides a comprehensive overview of Demodex blepharitis stemming from infestations of eyelash follicle mites. In this video segment featuring Dr. Elizabeth Yeu, an expert in ...

Please provide your email address to receive an email when new articles are posted on . The American Optometric Association Health Policy Institute has released a new brief to educate the public on ...

AJMC®: Does the prevalence of Demodex blepharitis found by Trattler and colleagues 1 match what you see in clinical practice? BRUJIC: The prevalence of Demodex blepharitis is interesting. Prior to ...

Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States. Despite being common, it is frequently underdiagnosed or mistaken for ...

Patients with psoriasis are at increased risk for cataracts, uveitis, dry eye disease, glaucoma, retinal vein occlusion (RVO) ...

Credit: Tarsus Pharmaceuticals. Xdemvy is supplied as an ophthalmic solution containing lotilaner 0.25% (2.5mg/mL) in a 10mL bottle; it is expected to be available by the end of August 2023. The Food ...

The FDA approved lotilaner ophthalmic solution 0.25% (Xdemvy) as the first specific treatment for Demodex blepharitis. Lotilaner (formerly TP-03) is an ectoparasiticide that targets Demodex mites, ...